Literature DB >> 11438716

Molecular targeting of cancer: telomeres as targets.

R Hodes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11438716      PMCID： PMC35393          DOI： 10.1073/pnas.151267698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  Telomeres and their control.

Authors:  M J McEachern; A Krauskopf; E H Blackburn
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

2.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

Review 3.  The role of telomerase expression and telomere length maintenance in human and mouse.

Authors:  N P Weng; R J Hodes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

4.  A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.

Authors:  M M Kim; M A Rivera; I L Botchkina; R Shalaby; A D Thor; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

6.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

8.  Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

Authors:  S K Nair; A Heiser; D Boczkowski; A Majumdar; M Naoe; J S Lebkowski; J Vieweg; E Gilboa
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

9.  The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes.

Authors:  R H Vonderheide; W C Hahn; J L Schultze; L M Nadler
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

10.  Cytotoxic T cell immunity against telomerase reverse transcriptase in humans.

Authors:  B Minev; J Hipp; H Firat; J D Schmidt; P Langlade-Demoyen; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205
View more
  8 in total

1.  Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.

Authors:  C-Q Su; J Sham; H-B Xue; X-H Wang; D Chua; Z-F Cui; L-H Peng; L-F Li; L-H Jiang; M-C Wu; Q-J Qian
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-09       Impact factor: 4.553

2.  Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.

Authors:  Chang-Qing Su; Xing-Hua Wang; Jie Chen; Yong-Jing Liu; Wei-Guo Wang; Lin-Fang Li; Meng-Chao Wu; Qi-Jun Qian
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 3.  Telomeres, telomerase, and tumorigenesis--a review.

Authors:  Lin Kah Wai
Journal:  MedGenMed       Date:  2004-07-26

Review 4.  Strategies targeting telomerase inhibition.

Authors:  Huaping Chen; Yuanyuan Li; Trygve O Tollefsbol
Journal:  Mol Biotechnol       Date:  2008-10-28       Impact factor: 2.695

5.  Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.

Authors:  Z Qi; R Mi
Journal:  Cancer Gene Ther       Date:  2016-01-08       Impact factor: 5.987

Review 6.  Does hereditary metabolic disease modulate senescence and ageing?

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

7.  Methods of telomerase inhibition.

Authors:  Lucy G Andrews; Trygve O Tollefsbol
Journal:  Methods Mol Biol       Date:  2007

8.  Antisense oligonucleotide against hTERT (Cantide) inhibits tumor growth in an orthotopic primary hepatic lymphoma mouse model.

Authors:  Bo Yang; Rui-li Yu; Shuai Tuo; Chao-wei Tuo; Qiu-zhen Liu; Ning Zhang; Xue-chun Lu; Xiao-hua Chi; Shu-bao Lv; Li-li Cai
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.